Chandan Healthcare (NSE:CHANDAN) Cash Flow for Dividends: ₹0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CHANDAN Chandan Healthcare Ltd NSE:CHANDAN
17 GF Score
Price ₹231.10
! 4 Warning Signs
View Full Analysis

What is Chandan Healthcare Cash Flow for Dividends?

Chandan Healthcare NSE:CHANDAN -4.01% 17 Cash Flow for Dividends is ₹0 Mil as of Dec. 2025. GuruFocus rates NSE:CHANDAN with a GF Score™ of 17/100. The stock has 4 warning signs investors should review.

Chandan Healthcare's cash flow for dividends for the three months ended in Dec. 2025 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Chandan Healthcare's annual payment of dividends increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹-25 Mil) and increased from Mar. 2024 (₹-25 Mil) to Mar. 2025 (₹-30 Mil).

Chandan Healthcare Cash Flow for Dividends Related Terms

Chandan Healthcare Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Chandan Healthcare's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandan Healthcare Cash Flow for Dividends Chart

Chandan Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Cash Flow for Dividends
-11.50 0.00 -24.85 -30.00

Chandan Healthcare Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:CHANDAN
17GF Score
Chandan Healthcare Ltd NSE:CHANDAN
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandan Healthcare Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Chandan Healthcare (NSE:CHANDAN) has a Cash Flow for Dividends of ₹0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Chandan Healthcare and its competitors.
Is Chandan Healthcare's Cash Flow for Dividends too high?
Chandan Healthcare's current Cash Flow for Dividends is ₹0 Mil. Overall, Chandan Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Cash Flow for Dividends compare to TMO and DHR?
Chandan Healthcare's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Diagnostics & Research company?
A good Cash Flow for Dividends depends on the Medical Diagnostics & Research industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Chandan Healthcare and its competitors. Chandan Healthcare's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Cash Flow for Dividends of ₹0 Mil. The current Cash Flow for Dividends is ₹0 Mil. Chandan Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Cash Flow for Dividends is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chandan Healthcare Business Description

Address Kursi Road, Biotech Park, Sector G, Jankipuram, Lucknow, UP, IND, 226021
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score

Get the complete analysis for NSE:CHANDAN

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹231.10
Price